Abstract
Kidneys are targets of numerous toxicants due to anatomical, physiological and biochemical features of the organs. Factors contributing to the sensitivity of kidneys include large blood flow, presence of a variety of transporters, a lot of functionally necessary metabolizing enzymes, etc. This paper reviews some mechanisms of nephrotoxic action of widely distributed metal compounds and of an anticancer drug cisplatin as a model of drug induced renal damage. Cisplatin is known to induce nephropathy that is restricted primarily to the S3, segment of the proximal tubule, with involvement of S2, and S1 segments at higher doses. This particularity appears to be derived from the distribution of enzymes and transport proteins important for uptake of cisplatin into proximal tubule cells: apical γ-glutamyltranspeptidase and the basolateral organic anion transport system. Regional distributions of transport mechanisms for binding proteins appear to be important in the expression of nephrotoxicity of cisplatin. According to the mechanism of damage the way to protect is proposed with application of antioxidants and mighty antioxidants such as cluster rhenium compounds with organic ligands that contain an unique quadruple bond are demonstrated as nephroprotectors in the model of tumor growth and cisplatin application.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Babiy SO, Dyomshyna OO, Shtemenko NI (2010) Influence antitumor system rhenium-platinum on the renal function in rats model of toxic nephropathy (in Russian). Bicник пpoблeм бioлoгiї тa мeдицини 3:94–101
Bernareggi A, Torti L, Facino RM et al (1995) Characterization of cisplatin-glutathione adducts by liquid chromatography mass spectrometry: evidence for their formation in vitro but not in vivo after concomitant administration of cisplatin and glutathione to rats and cancer patients. J Chromatogr 669:247–263
Bridges CC, Zalups RK (2005) Molecular and ionic mimicry and the transport of toxic metals. Toxicol Appl Pharmacol 204:274–308
Ercal N, Gurer-Orhan H, Aykin-Burns N (2009) Toxic metal and oxidative stress Part I: mechanisms involved in metal induced oxidative damage. Curr Top Med Chem 1:529–539
Evenepoel P (2004) Acute toxic renal failure. Best Pract Res Clin Anaesthesiol 18:37–52
Goldberg RM, Tabah-Fisch I, Bleiberg H et al (2006) Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 24:4085–4091
Gurer H, Ercal N (2000) Can antioxidants be beneficial in the treatment of lead poisoning. Free Radic Biol Med 29:927–945
Hanigan MH, Lykissa ED, Townsend DM et al (2001) γ-Glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. Am J Pathol 159:1889–1894
Hanigan MH, Deng M, Zhang L et al (2005) Stress response inhibits the nephrotoxicity of cisplatin. Am J Physiol Renal Physiol 288:125–132
Hultberg B, Anderson A, Isaksson A (2001) Interaction of metals and thiols in cell damage and glutathione distribution: potentiation of mercury toxicity by dithiothreitol. Toxicology 156:93–100
Ishikawa T, Ali-Osman F (1993) Glutathione-associated cis-diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. J Biol Chem 268:20116–20125
Ivchuk VV, Stemenko NI (2008) Hepatocyte functional activity of rats with cancerogenesis. Bull Dnipropetrovsk Natl Univ Biol Ecol (Ukrainian Lang) 16(2):60–64
Jones MM, Basinger MA, Holscher MA (1992) Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds. Fundam Appl Toxicol 18:181–188
Lavery TJ, Kemper CM, Sanderson K (2009) Heavy metal toxicity of kidney and bone tissues in South Australian adult bottlenose dolphins (Tursiops aduncus). Mar Environ Res 67:1–7
Lucena MI, Andrade RJ, Cabello MR (1995) Aminoglycoside-associated nephrotoxicity in extrahepatic obstructive jaundice. J Hepatol 22(2):189–196
Markowitz GS, Perazella MA (2005) Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chimica Acta 351:31–47
Mohammadirad A, Abdolahi M (2011) A systematic review on oxidant/antioxidant imbalance in aluminium toxicity. Int J Pharmacol 7(1):12–21
Pater ME, Mindiola DJ, Ouyang X et al (1998) A quadroply-bounded dirhenium complex bridged by two N1/N6 adenate ligands. Inorg Chem Commun 1:465–477
Perazella MA (2009) Renal vulnerability to drug toxicity. Clin J Am Soc Nephrol 4:1275–1283
Quig D (1998) Cysteine metabolism and metal toxicity. Altern Med Rev 3(4):262–270
Ries F, Klastersky J (1986) Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8(5):368–379
Sabolic I (2006) Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol 104:107–114
Sabolic I, Ljubojevic M, Herak-Kramberger CM et al (2002) Cd-MT causes endocytosis of brush-border transporters in rat renal proximal tubules. Am J Physiol Renal Physiol 283:1389–1402
Sadzuka Y, Shimizu Y, Takino Y et al (1994) Protection against cisplatin-induced nephrotoxicity in the rat by inducers and an inhibitor of glutathione S-transferase. Biochem Pharmacol 48:453–459
Sheikh-Hamad D (2008) Cisplatin-induced cytoxicity: is the nucleus relevant? Am J Physiol Renal Physiol 295:42–43
Shtemenko NI, Berzenina OV, Yegorova DE et al (2008) Liposomal forms of rhenium cluster compounds: enhancement of biological activity. Chem Biodivers 5:1660–1667
Shtemenko AV, Collery P, Shtemenko NI et al (2009) Synthesis, characrerization, in vivo antitumor properties of the cluster rhenium compound with GABA ligands and its synergism with cisplatin. Dalton Trans 26:5132–5136
Singh NP, Ganguli A, Prakash A (2003) Drug-induced kidney diseases. J Assoc Physicians India 51:970–979
Stohs SJ, Bagchi D (1995) Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18(2):321–336
Thevenod F (2003) Nephrotoxicity and the proximal tubule. Nephron Physiol 93:87–93
Townsend DM, Deng M, Zhang L et al (2003) Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 14:1–10
Uboh FE, Akpanabiatu MI, Ndem JI et al (2009) Comparative nephrotoxic effect associated with exposure to diesel and gasoline vapours in rats. J Toxicol Environ Health Sci 1(3):068–074
Valko M, Morris H, Cronin MTD (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12:1161–1208
Viale M, Vannozzi MO, Pastrone I et al (2000) Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role? J Pharmacol Exp Ther 293:829–836
Vleet TRV, Schnellmann RG (2003) Toxic nephropathy: environmental chemicals. Semin Nephrol 23(5):500–508
Wyatt CM, Arons RR, Klotman PE et al (2006) Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 20:561–565
Zadak Z, Hyspler R, Ticha A, Hronek M (2009) Antioxidants and vitamins in clinical conditions. Physiol Res 58(1):13–17
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this paper
Cite this paper
Babiy, S., Dyomshyna, O., Loskutova, T., Shtemenko, N.I. (2012). Environmental and Drug Induced Renal Damage; The Way to Protect. In: Vitale, K. (eds) Environmental and Food Safety and Security for South-East Europe and Ukraine. NATO Science for Peace and Security Series C: Environmental Security. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2953-7_23
Download citation
DOI: https://doi.org/10.1007/978-94-007-2953-7_23
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2952-0
Online ISBN: 978-94-007-2953-7
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)